Prenatal Diagnostic Testing Market

1
Prenatal Diagnostic Testing - Overview
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published April 2015
• Single User PDF US 2495
• Corporate User PDF US 9950

2
Prenatal Diagnostic Testing - Overview

• Prenatal Diagnostics Invasive Testing,
  Noninvasive Testing, and Rising Maternal
  Screening Methods for Preeclampsia and Preterm
  Labor. This report discusses improvements in
  invasive procedures (karyotyping vs.
  cytogenetics), and the rise of noninvasive
  screening methods and their impact on prenatal
  healthcare. Although covering standard invasive
  procedure, this report focuses on the noninvasive
  technologies either on the market or in
  development.
• Inquire for Discount _at_ http//www.reportsnreports.
  com/contacts/Discount.aspx?name440262
• Single User License US 2495
• Highlighting noninvasive methods, several
  companies have come out with novel technologies
  that allow them to analyze fetal DNA without risk
  of injury to the mother or fetus. Amniocentesis
  and chorionic villus sampling are common methods
  used to analyze fetal DNA for aneuploidies but at
  the risk of miscarriage and infection. With
  noninvasive procedures, screening can be done for
  common aneuploidies and further analysis can be
  done on women with only positive results. This
  not only decreases the amount of unnecessary
  invasive testing but also the amount of
  unnecessary stress levels of many expecting
  mothers. Companies participating in this section
  include  
• Sequenom, Verinata Health, Ariosa Diagnostics,
  Natera, Silicon Biosystems

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Prenatal Diagnostic Testing - Overview

• Report Highlights
• Company goals, customer feedback, challenges
  encountered, competitive advantage, platform
  pricing, and future endeavors
• An exclusive Reports survey specifically
  highlighting organizational background, areas of
  research, challenges encountered, and
  applications in development
• Clinical trial and pipeline data on over 120
  products
• Over 130 Company Profiles
• Exclusive interviews with
• Vardit Ravitsky, PhD Associate Professor,
  Bioethics Programs, School of Public Health,
  University of Montreal
• Tom Musci, Chief Medical Officer of Ariosa
  Diagnostics
• Richard Rava, Vice President, Research and
  Development of Verinata
• Solomon Moshkevich, Vice-President, Marketing and
  Business Development of Natera
• Robert Proulx, President GM U.S. Operations of
  Silicon Biosystems
• Charles Garvey, Chief Executive Officer of
  Metabolomic Diagnostics
• Dr. Alan Ezrin and Brian Brohman, Co-Founder,
  Chief  Executive Officer of NX PharmaGen Chief
  Business Officer of NX PharmaGen

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Prenatal Diagnostic Testing - Overview

• William Welch Dirk van den Boom and Allan
  Bombard, President and Chief Operating Officer of
  Sequenom Executive Vice President, Research
  Development and Chief Technology Officer of
  Sequenom Chief Medical Officer of Sequenom
• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name440262
• Single User License US 2495
• Executive Summary
• Prenatal diagnostics is a rapidly expanding
  field. Many of the technologies coming out now
  have several noticeable pros and cons, but the
  hype is that newer methods are able to detect
  prenatal abnormalities without using invasive
  procedures.
• Complete report is spread across 140 pages and
  available _at_ http//www.reportsnreports.com/reports
  /440262-prenatal-diagnostic-testing-overview.html
• In addition to covering several aspects of
  prenatal diagnostics, this report also includes
  specifications of particular instruments, and
  exclusive interviews with CEOs, CSOs, and Vice
  Presidents of the participating companies.
  Specific areas of focus include company goals,
  customer feedback, challenges encountered,
  competitive advantage, platform pricing, and
  future endeavors. A survey capturing the
  demographics of the prenatal industry is
  presented at the end of the report, specifically
  highlighting organizational background, areas of
  research, challenges encountered, and
  applications in development. Also included is a
  directory of companies that were and were not
  interviewed for this report.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Prenatal Diagnostic Testing - Overview

• Browse All Reports on Healthcare Market.
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Prenatal
  Diagnostic Testing Overview report OR for any
  other market research and intelligence needs you
  may have for your business.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.